Association of venetoclax-based therapy with increased survival in multiple myeloma (MM) harboring t(11;14): A single-center experience

被引：0
|
作者：
Ionescu, Filip
Patel, Parth
Thapa, Shrinjaya
Drekolias, Dimitrios
Blue, Brandon Jamaal
Puglianini, Omar Alexis Castaneda
Ochoa-Bayona, Jose L.
Freeman, Ciara L.
Liu, Hien
Hansen, Doris K.
Nishihori, Taiga
Silva, Ariosto
Sudalagunta, Praneeth Reddy
Brayer, Jason B.
Alsina, Melissa
Shain, Kenneth H.
Baz, Rachid C.
Grajales-Cruz, Ariel Felipe
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ S Florida, Tampa, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20055
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Single-Center Experience on the Safety and Efficacy of Venetoclax-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma
    Zolotov, Eli
    Patel, Vanisha
    Weiss, Yedidyah
    Biran, Noa
    Phull, Pooja
    Vesole, David H.
    Siegel, David S.
    Parmar, Harsh
    BLOOD, 2024, 144 : 6959 - 6960
  • [2] Clinical Efficacy of Retreatment With Venetoclax-Based Therapy in Relapsed-Refractory t(11;14) Multiple Myeloma
    Dima, Danai
    Orland, Mark
    Ullah, Fauzia
    Anwer, Faiz
    Mazzoni, Sandra
    Raza, Shahzad
    Chaulagain, Chakra P.
    Samaras, Christy
    Valent, Jason
    Williams, Louis
    Khouri, Jack
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (11): : 857 - 860
  • [3] Venetoclax-based salvage in multiple myeloma with (11;14) translocation after suboptimal response to first-line therapy
    Reka, Szita Virag
    Adam, Wiedemann
    Szabolcs, Syoreni
    Andras, Toth
    Eszter, Ruff
    Lilla, Gaal
    Tamas, Masszi
    Gergely, Varga
    ORVOSI HETILAP, 2023, 164 (23) : 894 - 899
  • [4] Unexpected Equal Long-term Overall Survival of Multiple Myeloma Harboring t(11;14), or t(4;14): A Retrospective Single Center Study
    Hardi, Apor
    Bors, Andras
    Andrikovics, Hajnalka
    Mikala, Gabor
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S328 - S329
  • [5] Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma
    Basali, Diana
    Chakraborty, Rajshekhar
    Rybicki, Lisa
    Rosko, Nathaniel
    Reed, Janice
    Karam, Mary Ann
    Schlueter, Kristen
    Dysert, Hayley
    Faiman, Beth M.
    Hamilton, Kimberly
    Kalaycio, Matt
    Valent, Jason
    BLOOD, 2019, 134
  • [6] Real-world data on safety and efficacy of venetoclax-based regimens in relapsed/refractory t(11;14) multiple myeloma
    Basali, Diana
    Chakraborty, Rajshekhar
    Rybicki, Lisa
    Rosko, Nathaniel
    Reed, Janice
    Karam, Maryann
    Schlueter, Kristen
    Dysert, Hayley
    Kalaycio, Matt
    Valent, Jason
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (06) : 1136 - 1140
  • [7] Effective venetoclax-based treatment in relapsed/refractory multiple myeloma patients with translocation t(6;14)
    Cegledi, Andrea
    Csukly, Zoltan
    Fekete, Monika
    Kozma, Andras
    Szemlaky, Zsuzsanna
    Andrikovics, Hajnalka
    Mikala, Gabor
    PATHOLOGY & ONCOLOGY RESEARCH, 2023, 29
  • [8] Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma
    Kumar, Shaji
    Kaufman, Jonathan L.
    Gasparetto, Cristina
    Mikhael, Joseph
    Vij, Ravi
    Pegourie, Brigitte
    Benboubker, Lofti
    Facon, Thierry
    Amiot, Martine
    Moreau, Philippe
    Punnoose, Elizabeth A.
    Alzate, Stefanie
    Dunbar, Martin
    Xu, Tu
    Agarwal, Suresh K.
    Enschede, Sari Heitner
    Leverson, Joel D.
    Ross, Jeremy A.
    Maciag, Paulo C.
    Verdugo, Maria
    Touzeau, Cyrille
    BLOOD, 2017, 130 (22) : 2401 - 2409
  • [9] Long-term survival in multiple myeloma: a single-center experience
    Francesca Merchionne
    Pasquale Procaccio
    Franco Dammacco
    Clinical and Experimental Medicine, 2008, 8 : 133 - 139
  • [10] Long-term survival in multiple myeloma: a single-center experience
    Merchionne, Francesca
    Procaccio, Pasquale
    Dammacco, Franco
    CLINICAL AND EXPERIMENTAL MEDICINE, 2008, 8 (03) : 133 - 139
12345